Tolvaptan in Hyponatremic Cancer Patients

NCT01199198 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

52

Enrollment

OTHER

Sponsor class

Conditions

Advanced Cancers

Interventions

DRUG: Tolvaptan
DRUG: Placebo

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]